Ticker >

Amkay Products share price

Amkay Products Ltd.

BSE: 544169 SECTOR: Medical Equipment/Supplies/Accessories  1814   5   1

73.00
-0.01 (-0.01%)
BSE: 12 Jun 04:01 PM

Price Summary

Today's High

₹ 73.01

Today's Low

₹ 71

52 Week High

₹ 120.96

52 Week Low

₹ 57.6

FinStar

Ownership Very Stable
High level of belief in company’s potential exhibited by insiders.
ValuationAttractive
The stock is considerably attractive based on intrinsic value.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

63.19 Cr.

Enterprise Value

67.84 Cr.

No. of Shares

0.87 Cr.

P/E

24.03

P/B

2.39

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  30.54

CASH

0.05 Cr.

DEBT

4.7 Cr.

Promoter Holding

73.44 %

EPS (TTM)

₹  3.04

Sales Growth

-23.67%

ROE

22 %

ROCE

24.73%

Profit Growth

4.57 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Index Presence

The company is present in 1 Indices.

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-23.67%
3 YearNA
5 YearNA

Profit Growth

1 Year4.57%
3 YearNA
5 YearNA

ROE%

1 Year22%
3 Year38.26%

ROCE %

1 Year24.73%
3 Year41.99%

Debt/Equity

0.6072

Price to Cash Flow

64.67

Interest Cover Ratio

5.69995988768552

CFO/PAT (5 Yr. Avg.)

0

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2024 73.44 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company has been maintaining healthy ROE of 38.2634291484607% over the past 3 years.
  • Company has been maintaining healthy ROCE of 41.9890346871189% over the past 3 years.
  • The company has an efficient Cash Conversion Cycle of 7.1070605609968 days.
  • The company has a high promoter holding of 73.44%.

 Limitations

  • The company has shown a poor profit growth of 0% for the Past 3 years.
  • The company has shown a poor revenue growth of 0% for the Past 3 years.
  • The company has a low EBITDA margin of 0% over the past 5 years.

Quarterly Result (All Figures in Cr.)

Quarterly Data is not available for this company.Report us

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023
Net Sales 40.7 36.5 27.86
Total Expenditure 36.11 33.82 24.7
Operating Profit 4.59 2.69 3.17
Other Income 0.08 0.29 0.39
Interest 0.21 0.41 0.5
Depreciation 0.28 0.54 0.71
Exceptional Items 0 0 0
Profit Before Tax 4.18 2.04 2.34
Tax 1.05 0.57 0.81
Net Profit 3.13 1.47 1.53
Adjusted EPS (Rs.) 4.91 2.31 2.41

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 0.28 0.28 0.28
Total Reserves 4.46 5.93 7.46
Borrowings 1.35 3.47 3.35
Other N/C liabilities -0.25 -0.19 0.02
Current liabilities 7.8 6.08 4.52
Total Liabilities 13.64 15.57 15.63
Assets
Net Block 2.3 3.91 3.26
Capital WIP 0 0 0
Intangible WIP 0 0 0
Investments 0.4 1.66 3.23
Loans & Advances 0.67 0.47 0.29
Other N/C Assets 0 0 0
Current Assets 10.27 9.52 8.85
Total Assets 13.64 15.57 15.63
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023
Profit from operations 4.18 2.04 2.34
Adjustment 0.35 0.77 0.76
Changes in Assets & Liabilities -0.03 -2.55 -1.52
Tax Paid -1.12 -0.52 -0.6
Operating Cash Flow 3.38 -0.25 0.98
Investing Cash Flow -1.98 -3.07 -1.39
Financing Cash Flow -0.65 2.59 0.26
Net Cash Flow 0.76 -0.72 -0.15

Corporate Actions

Investors Details

PARTICULARS Mar 2024%
promoters 73.44
giriraj stocks & securiti... 6.21
hemanshu kantilal batavia... 13.31
hiral kashyap mody 4.38
kashyap pravin modi huf 13.72
kashyap pravin mody 30.95
pravin v mody huf 3.54
pravin vrajlal mody 1.33
PARTICULARS Mar 2024%
investors 26.56
hem finlease private limi... 1.39
meru investment fund pcc-... 2.77
visionary value fund 4.81

Annual Reports

No Annual reports exist for this company.Report us

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Amkay Products Stock Price Analysis and Quick Research Report. Is Amkay Products an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. Amkay Products stock price today is Rs 73. So, let’s look into Amkay Products and its performance over the period of time. 

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Its cash from the operating activity was Rs 0.9771 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Amkay Products has a Debt to Equity ratio of 0.6072 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Amkay Products , the EPS growth was 4.57207304906086 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Amkay Products has OPM of 11.3611731181947 % which is a bad sign for profitability.
     
  • ROE: Amkay Products have a healthy ROE of 22.0015344571679 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Amkay Products is Rs 73. One can use valuation calculators of ticker to know if Amkay Products share price is undervalued or overvalued.
Last Updated on:
Brief about Amkay Products
X